Companies and Market

share

Sarepta Therapeutics plans to raise $375m through the private placement of convertible senior unsecured notes. Due 15 November 2024,...

share

Biopharmaceutical company Cerenis Therapeutics is set to acquire Lypro Biosciences assets, a portfolio of drug delivery nanotechnology. The...

share

US-based private equity firm Egyptian American Enterprise Fund (EAEF) has acquired 46.5% stake in Egyptian ophthalmic pharmaceutical products...

share

An update provided by the India Brand Equity foundation (IBEF) and the Pharmaceuticals Export Promotion Council (PHARMEXCIL) showed...

share

CSL Behring, the US subsidiary of Australia-based CSL has agreed to acquire Calimmune, an American biotechnology company focused...

share

TrialScope has announced the launch its second Clinical Trial Disclosure Maturity Survey for clinical trial sponsors to perform...

share

The US Food and Drug Administration (FDA) has approved the Bavencio (avelumab) injection developed by Merck and Pfizer...

6 shares

Botox maker Allergan Plc agreed to pay $2.48 billion in cash for Zeltiq Aesthetics Inc, adding a system...